The role of AnxA2 in the carcinogenesis of human cancers is still debated as it has been shown to be overexpressed in some cancers and downregulated in others, both of which have been identified as beneficial to cancer cells depending on location (Liu et al., 2003; Zhai et al., 2011). The gene discussed is ANXA2; the disease is cancer.